Peter-James H. Zushin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Peter-James H. Zushin has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Andreas Stahl
Department of Nutrition and Toxicology, University of California Berkeley, Berkeley, USA
2 shared publications - Amanda Lestari Gunawan
Department of Nutritional Sciences and Toxicology, University of California, Berkeley, CA, 94720, USA
1 shared publication Ambre M. Bertholet
Department of Physiology, University of California
1 shared publicationBiao Wang
Cardiovascular Research Institute, Department of Physiology, University of California
1 shared publicationCameron Cornn
Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine
1 shared publicationChing-Fang Chang
Department of Nutritional Sciences and Toxicology, University of California
1 shared publication
Latest Publications
- Open Access
G protein-coupled receptor 151 regulates glucose metabolism and hepatic gluconeogenesis
Human genetics has been instrumental in identification of genetic variants linked to type 2 diabetes (T2D). Recently a rare, putative loss-of-function mutation in the orphan G-protein coupled receptor 151 ( GPR151 ) was found to be associated with lower odds ratio for T2D, but the mechanism behind this association has remained elusive. Here for the first time we show that Gpr151 is a fasting- and glucagon-responsive hepatic gene which regulates hepatic gluconeogenesis. Gpr151 ablation in mice leads to suppression of hepatic gluconeogenesis genes and reduced hepatic glucose production in response to pyruvate. Importantly, the restoration of hepatic Gpr151 levels in the Gpr151 knockout mice reverses the reduced hepatic glucose production. Our findings establish a previously unknown role of Gpr151 in the liver and provides an explanation to the lowered T2D risk in individuals with nonsynonymous mutations in GPR151 . This study highlights the therapeutic potential of targeting GPR151 for treatment of metabolic disease.
Open AccessG protein-coupled receptor 151 regulates glucose metabolism and hepatic gluconeogenesis
Human genetics has been instrumental in identification of genetic variants linked to type 2 diabetes (T2D). Recently a rare, putative loss-of-function mutation in the orphan G-protein coupled receptor 151 ( GPR151 ) was found to be associated with lower odds ratio for T2D, but the mechanism behind this association has remained elusive. Here for the first time we show that Gpr151 is a fasting- and glucagon-responsive hepatic gene which regulates hepatic gluconeogenesis. Gpr151 ablation in mice leads to suppression of hepatic gluconeogenesis genes and reduced hepatic glucose production in response to pyruvate. Importantly, the restoration of hepatic Gpr151 levels in the Gpr151 knockout mice reverses the reduced hepatic glucose production. Our findings establish a previously unknown role of Gpr151 in the liver and provides an explanation to the lowered T2D risk in individuals with nonsynonymous mutations in GPR151 . This study highlights the therapeutic potential of targeting GPR151 for treatment of metabolic disease.
- Open Access
Coenzyme Q regulates UCP1 expression and thermogenesis through the integrated stress responses
Coenzyme Q (CoQ) is an essential component of mitochondrial respiration 1 and required for thermogenic activity in brown adipose tissues 2 (BAT). CoQ deficiency leads to a wide range of pathological manifestations 3 but mechanistic consequences of CoQ deficiency in specific tissues such as BAT remain poorly understood. Here we show that pharmacological or genetic CoQ deficiency (50-75% reduction) in BAT leads to accumulation of cytosolic mitochondrial RNAs (mtRNAs) and activation of the eIF2α kinase PKR resulting in the induction of the integrated stress response (ISR) and suppression of UCP1 expression in an ATF4-dependent fashion. Surprisingly, despite diminished UCP1 levels, BAT CoQ deficiency increases whole-body metabolic rates at room temperature and thermoneutrality resulting in decreased weight gain on high fat diets (HFD). This mitohormesis like effect of BAT CoQ insufficiency is dependent on the ATF4-FGF21 axis in BAT revealing an unexpected role for CoQ in the modulation of whole-body energy expenditure with wide-ranging implications for primary and secondary CoQ deficiencies.
Open AccessCoenzyme Q regulates UCP1 expression and thermogenesis through the integrated stress responses
Coenzyme Q (CoQ) is an essential component of mitochondrial respiration 1 and required for thermogenic activity in brown adipose tissues 2 (BAT). CoQ deficiency leads to a wide range of pathological manifestations 3 but mechanistic consequences of CoQ deficiency in specific tissues such as BAT remain poorly understood. Here we show that pharmacological or genetic CoQ deficiency (50-75% reduction) in BAT leads to accumulation of cytosolic mitochondrial RNAs (mtRNAs) and activation of the eIF2α kinase PKR resulting in the induction of the integrated stress response (ISR) and suppression of UCP1 expression in an ATF4-dependent fashion. Surprisingly, despite diminished UCP1 levels, BAT CoQ deficiency increases whole-body metabolic rates at room temperature and thermoneutrality resulting in decreased weight gain on high fat diets (HFD). This mitohormesis like effect of BAT CoQ insufficiency is dependent on the ATF4-FGF21 axis in BAT revealing an unexpected role for CoQ in the modulation of whole-body energy expenditure with wide-ranging implications for primary and secondary CoQ deficiencies.